Guidance language now reflects anticipation of FDA decision upon post-market study plan approval, compared to prior uncertainty about regulatory timing. The focus on US commercialization and sales ...

The latest part of the Federal Acquisition Regulation (FAR) to undergo a rewrite is FAR Part 10, which addresses market ...